System proteinase/inhibitors in the pathogenesis of experimental kidney tuberculosis



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Damage to the kidney parenchyma of various origins is associated with the accumulation of extracellular matrix proteins, the regulation of which involves the matrix metalloproteinase/inhibitor system.

AIM: To evaluate the pathogenetic role of the proteinase/blood inhibitor system in experimental renal tuberculosis.

MATERIAL AND METHODS: When modeling the process, a clinical strain 5582 of the Beijing genotype with multidrug resistance of mycobacteria was used. The study was conducted on 20 rabbits, divided into three groups: the first (n=6) included infected untreated animals; in the second (n=7) and third (n=7) anti-tuberculosis therapy was administered orally for 18.5 weeks; in the third, treatment was carried out in combination with a single injection of autologous mesenchymal stem cells into the ear vein. Blood levels of matrix metalloproteinases-1 and -9, tissue inhibitor of metalloproteinases-1, cystatin C and neutrophil elastase were determined. Morphological changes in the kidney parenchyma at the end of the experiment were assessed using 26 indicators, including tubulointerstitial and vascular changes. The median and interquartile ranges were calculated, the Kruskal–Wallis test, analysis of covariance, and the projective classification method were used.

RESULTS: The progression of kidney tuberculosis was accompanied by a significant increase in the level of neutrophil elastase by 1.9 times, matrix metalloproteinase-9 by 2.2 times, and cystatin C by 1.5 times compared to the initial level. The treatment carried out in the second and third groups contributed to the normalization of these indicators. The concentrations of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in all three groups did not change relative to the baseline level. Covariance analysis showed that in the pathogenesis of renal tuberculosis changes in matrix metalloproteinase-1 (p=0.003), matrix metalloproteinase-9 (p=0.002), tissue inhibitor of metalloproteinases-1 (p=0.01) and cystatin C (p=0.0001) were primarily associated with vascular changes, found in all study groups. A linear combination containing three morphological characteristics allowed us to identify differences between the three groups with 90% accuracy.

CONCLUSION: Renal tuberculosis, caused by a multidrug-resistant pathogen, is characterized by an imbalance in the proteinase/inhibitor system and impaired renal function, the degree of which is associated with the morphological characteristics of vascular and tubulointerstitial changes.

Full Text

Restricted Access

About the authors

Dilyara S. Esmedlyaeva

St. Petersburg Research Institute of Phthisiopulmonology

Author for correspondence.
Email: diljara-e@yandex.ru
ORCID iD: 0000-0002-9841-0061
SPIN-code: 9402-4487
Scopus Author ID: 23110578300

Сand. Sci. (Biol.), Senior Researcher, Research Laboratory of microbiology, biochemistry and immunogenetics

Russian Federation, St. Petersburg

Nina P. Alekseeva

St. Petersburg State University

Email: ninaalexeyeva@mail.ru
ORCID iD: 0000-0001-8837-6739
SPIN-code: 2478-2746

Сand. Sci. (Physical and Mathematical), Assoc. Prof., Depart. of Scientific Technical Information Department

Russian Federation, St. Petersburg

Natalya M. Blum

Military Medical Academy named after S.M. Kirov

Email: blumn@mail.ru
ORCID iD: 0000-0003-1445-6714
SPIN-code: 4492-6190

ст. преподаватель, каф. патологической анатомии

Russian Federation, St. Petersburg

Marina E. .Dyakova

St. Petersburg Research Institute of Phthisiopulmonology

Email: marinadyakova@yandex.ru
ORCID iD: 0000-0002-7810-880X
SPIN-code: 7858-4573

Dr. Sci. (Biol.), Senior Researcher, Research Laboratory of microbiology, biochemistry and immunogenetics

Russian Federation, St. Petersburg

Tatiana I. Vinogradova

St. Petersburg Research Institute of Phthisiopulmonology

Email: vinogradova@spbniif.ru
ORCID iD: 0000-0002-5234-349X
SPIN-code: 6354-5070

MD, Dr. Sci. (Med.), Prof., Head, Research Laboratory of Experimental Medicine

Russian Federation, St. Petersburg

References

  1. Kulchavenya EV, Zhukova II, Kholtobin DP, Brizhayuk EV, Khomyakov VT, Osadchiy AV. Demographic and clinical characteristics of the modern urogenital tuberculosis. Meditsinskiy alyans. 2013;(4):71–77. (In Russ.) EDN: SNIDWZ
  2. Kim EJ, Lee W, Jeong WY, Choi H, Jung IY, Ahn JY, Jeong SJ, Ku NS, Choi JY, Choi YH, Song YG, Kim JM. Chronic kidney disease with genitourinary tuberculosis: Old disease but ongoing complication. BMC Nephrol. 2018;19(1):1–8. doi: 12882-018-0994-2
  3. Saganova ES, Zubina IM, Bogdanova EO, Galkina OV, Sipovskii VG, Smirnov AV. Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies. Therapeutic archive. 2021;93(6):699–705. (In Russ.) doi: 10.26442/00403660.2021.06.200850
  4. Wozniak J, Floege J, Ostendorf T, Ludwig A. Key metalloproteinase-mediated pathways in the kidney. Nat Rev Nephrol. 2021;17(8):513–527. doi: 10.1038/s41581-021-00415-5
  5. Chang M. Matrix metalloproteinase profiling and their roles in disease. RSC Adv. 2023;13(9):6304–6316. doi: 10.1039/d2ra07005g
  6. Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis Immunol Lett. 2018;196:80–90. doi: 10.1016/j.imlet.2018.01.006
  7. Ferguson TW, Komenda P, Tangri N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens. 2015;24(3):295–300. doi: 10.1097/MNH.0000000000000115
  8. Remezova AA, Gorelova AA, Muraviev AN, Gorelov AI, Gorbunov AI, Vinogradova TI, Zabolotnykh NV, Orlova NV, Sheikhov MG, Yudintseva NM, Nashchekina YA, Yablonskiy PK. Application of mesenchymal stem cells in kidney and urinary tract diseases: literature review and own experience. Meditsinskiy alyans. 2021;9(2):34–43. (In Russ.) doi: 10.36422/23076348-2021-9-2-34-43
  9. Muraviov AN, Vinogradova TI, Remezova AN, Ariel BM, Gorelova AA, Orlova NV, Yudintceva NM, Esmedliaeva DS, Dyakova ME, Zabolotnyh NV, Dogonadze MZ, Garapach IA, Maslak OS, Kirillov YuA, Timofeev SE, Kirylova YuS, Yablonskiy PK. The use of mesenchymal stem cells in the complex treatment of kidney tuberculosis (experimental study). Biomedicines. 2022;10(12):3062. doi: 10.3390/biomedicines10123062
  10. Muravyov AN, Vinogradova TI, Dogonadze MZ, Esmedliaeva DS, Dyakova ME, Orlova NV, Gorelova AA, Remezova AN, Zabolotnyh NV, Yudintceva NM, Sokolovich EG, Yablonskiy PK. Sposob modelirovaniya tuberkuleza pochki. (Method of modeling kidney tuberculosis.) Patent RUS No. 2776130 C1. Application Nо. 2021120918. (In Russ.) EDN: HFLUAT
  11. Visser L., Blout E. The use of P-Nitrophenil-N-Tertbutyloxylcarbonyl L-Alaninate as substate for elastase. Biochim Biophys Acta BBA-Enzymol. 1972;268:257–260. doi: 10.1016/0005-2744(72)90223-9
  12. Alekseeva NP, Gorlova IA, Bondarenko BB. Forecasting hypertension risk based on the method of projective classification. Arterialnaya gypertenziya. 2017;23(5):472–480. (In Russ.) doi: 10.18705/1607-419X-2017-23-5-472-480
  13. Zakiyanov O, Kalousová M, Zima T, Tesař V. Matrix metalloproteinases in renal diseases: A critical appraisal. Kidney Blood Press Res. 2019;44(3):298–330. doi: 10.1159/000499876
  14. Wu XJ, Dong ZQ, Lu QH. The role of cystatin C in vascular remodeling of balloon-injured abdominal aorta of rabbits. Mol Biol Rep. 2014;41(9):6225–6231. doi: 10.1007/s11033-014-3502-1
  15. Levitskaya ES. Mechanisms of formation of kidney fibrosis based on microvascular lesions. Medical Herald of the South of Russia. 2017;(1):21–27. (In Russ.) doi: 10.21886/2219-8075-2017-1-21-27

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2024 Eco-Vector





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies